References to Primary Literature
- HECTOR RF: Review of antifungal patents appearingJuly 1993 to March 1994. Exp. Opin. Ther. Patents (1994) 4(8): 911–916.
- HUNTER PA: New developments in non-azole antlfun-gals for human use. In Fifty Years of Antimicrobials (1995), Cambridge University Press, Hunter, Darby and Russell (Eds.), pp 18–51.
- HUNTER PA: Antibacterial patent activity: October 1992 to March 1993. Exp. Opin. Ther. Patents (1993) 3(10):1475–1486.
- DUNCAN K: Tuberculosis: current status and recentdevelopments in diagnostics, drugs and vaccines. E. Opin. Then Patents (1996) 6(2):175–185.
- RANE DF, DASMAHAPATRA B, SCHWARTZ J: Recent ad-vances in anti-HIV agents. Exp. Opin. Ther. Patents (1994) 4(8):941–955.
- MOORMAN AR: Varicella-zoster antiviral agents. Exp. Opin. Ther. Patents (1994) 4(2):121–129.
- WHITTINGTON A, BETHELL R: Recent developments in the antiviral therapy of influenza. Exp. Opin. Ther. Patents (1995) 5(8):793–803.
- CROFT SL: Antiprotozoal drugs: some echoes, someshadows. In Fifty Years of Antimicrobials (1995), Cambridge University Press, Hunter, Darby and Russell (Eds.), pp.299–326.
- PUDNEY M: Antimalariab: from quinine to atovaquone.In Fifty Years of Antimicrobials (1995), Cambridge University Press, Hunter, Darby and Russell (Eds.), pp.229–247.
- HIDER RC: The treatment of malaria with iron chelators.Exp. Opin. Ther. Patents (1994) 4(8):931–940.